Evidence map›Paper›PMID 41761335›Full record

ArticleStem cell research & therapy2026

Desmin mutations in cardiomyocytes increase susceptibility to coxsackievirus B3 infection by impairing antiviral IFN-β response and upregulating viral receptors expression.

Domitille Callon, Yeranuhi Hovhannisyan, Gabriel Friob, Jean-Sébastien Vartanian-Grimaldi, Brice-Emmanuel Guennec, Anne-Laure Lebreil, Zhenlin Li, Rodolphe Suspène, Laurent Andreoletti, Paul Fornès and 4 more

Abstract read
In one paragraph

Article in Stem cell research & therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Domitille CallonInstitut de Biologie Paris-Seine (IBPS), UMR CNRS 8263, INSERM U1345, Development, Adaptation and Ageing, Sorbonne Université, Paris, France. dcallon@chu-reims.fr.
Yeranuhi HovhannisyanInstitut de Biologie Paris-Seine (IBPS), UMR CNRS 8263, INSERM U1345, Development, Adaptation and Ageing, Sorbonne Université, Paris, France.
Gabriel FriobInstitut de Biologie Paris-Seine (IBPS), UMR CNRS 8263, INSERM U1345, Development, Adaptation and Ageing, Sorbonne Université, Paris, France.
Jean-Sébastien Vartanian-GrimaldiInstitut de Biologie Paris-Seine (IBPS), UMR CNRS 8263, INSERM U1345, Development, Adaptation and Ageing, Sorbonne Université, Paris, France.
Brice-Emmanuel GuennecInstitut de Biologie Paris-Seine (IBPS), UMR CNRS 8263, INSERM U1345, Development, Adaptation and Ageing, Sorbonne Université, Paris, France.
Anne-Laure LebreilINSERM UMR-S1320 Cardiovir, University of Reims Champagne Ardennes, Reims, France.
Zhenlin LiInstitut de Biologie Paris-Seine (IBPS), UMR CNRS 8263, INSERM U1345, Development, Adaptation and Ageing, Sorbonne Université, Paris, France.
Rodolphe SuspèneVirus and Cellular Stress Unit, Department of Virology, Institut Pasteur, Université Paris Cité, Paris, France.
Laurent AndreolettiINSERM UMR-S1320 Cardiovir, University of Reims Champagne Ardennes, Reims, France.
Paul FornèsINSERM UMR-S1320 Cardiovir, University of Reims Champagne Ardennes, Reims, France.
Fatma BerriINSERM UMR-S1320 Cardiovir, University of Reims Champagne Ardennes, Reims, France.
Jean-Pierre VartanianVirus and Cellular Stress Unit, Department of Virology, Institut Pasteur, Université Paris Cité, Paris, France.
Pierre JoanneInstitut de Biologie Paris-Seine (IBPS), UMR CNRS 8263, INSERM U1345, Development, Adaptation and Ageing, Sorbonne Université, Paris, France. pierre.joanne@sorbonne-universite.fr.
Onnik AgbulutInstitut de Biologie Paris-Seine (IBPS), UMR CNRS 8263, INSERM U1345, Development, Adaptation and Ageing, Sorbonne Université, Paris, France. onnik.agbulut@sorbonne-universite.fr.

Funding

AFM-Téléthon 22142
6 · The paper itself

Abstract

backgroundDesmin-related cardiomyopathies caused by mutations in the DES gene are characterized by cytoskeletal disorganization and impaired cardiomyocyte function. Viral infections, particularly with Coxsackievirus B3 (CVB3), have been implicated as environmental triggers for cardiac decompensation. However, the interaction between desmin mutations and viral infection has never been explored.

methodsHuman induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) from a healthy donor (control-CMs) and from patients carrying DES

resultsDES

conclusionCVB3/28 infection compromises the structural integrity and contractile function of cardiomyocytes and exerts a more severe effect in cells harboring DES mutations. These findings underscore a pathogenic synergy between genetic cytoskeletal defects and viral infection, revealing a mechanistic basis for the heightened vulnerability of patients carrying mutation in DES gene to virus-induced cardiac decompensation. CVB3/28 infection disrupts cardiomyocyte structure and impairs contractility, with more severe effects in cells carrying DES mutations. By enhancing viral replication and weakening antiviral defenses, DES mutations act synergistically with CVB3/28 infection to increase the risk of cardiac dysfunction.

Indexed as

Coxsackievirus InfectionsDesminEnterovirus B, HumanInterferon-betaMyocytes, CardiacReceptors, VirusHumansInduced Pluripotent Stem CellsMutationUp-RegulationVirus ReplicationDesminInterferon-betaReceptors, VirusCardiomyocytesDesminDilated cardiomyopathyEnterovirusiPSCMyocarditis

Identifiers

PMID41761335
PMCPMC13049878

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.